Yifeng Pharmacy Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Yifeng Pharmacy cash flow conversion efficiency. Based on the latest financial reports, Yifeng Pharmacy (603939) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥641.93 Million ≈ $93.93 Million USD) by net assets (CN¥11.66 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Yifeng Pharmacy (2011–2024)

Cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024. This chart illustrates how Yifeng Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Yifeng Pharmacy stock price today for real-time trading data and today's change.

Yifeng Pharmacy Cash Flow Conversion Ratio Explained

Yifeng Pharmacy cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Yifeng Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifeng Pharmacy ranked by their cash flow conversion efficiency. Also see Yifeng Pharmacy market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
AT & S Austria Technologie & Systemtechnik Aktiengesellschaft
VI:ATS
0.078x
Exchange Income Corporation
TO:EIF
0.112x
ViTrox Corporation Bhd
KLSE:0097
0.029x
Qingdao TGOOD Electric Co Ltd
SHE:300001
0.107x
Umicore S.A.
BR:UMI
-0.029x
SWIGGY LIMITED
NSE:SWIGGY
-0.018x
Suzhou TA&A Ultra Clean Technology Co Ltd
SHE:300390
-0.037x
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
0.035x

Annual Cash Flow Conversion Efficiency for Yifeng Pharmacy (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024. Review 603939 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥11.39 Billion
≈ $1.67 Billion
CN¥4.22 Billion
≈ $617.70 Million
0.370x -17.00%
2023-12-31 CN¥10.45 Billion
≈ $1.53 Billion
CN¥4.66 Billion
≈ $682.38 Million
0.446x +3.86%
2022-12-31 CN¥9.12 Billion
≈ $1.33 Billion
CN¥3.92 Billion
≈ $573.66 Million
0.430x +57.21%
2021-12-31 CN¥7.86 Billion
≈ $1.15 Billion
CN¥2.15 Billion
≈ $314.61 Million
0.273x +18.34%
2020-12-31 CN¥5.78 Billion
≈ $846.10 Million
CN¥1.34 Billion
≈ $195.45 Million
0.231x +12.93%
2019-12-31 CN¥4.71 Billion
≈ $689.07 Million
CN¥963.23 Million
≈ $140.95 Million
0.205x +67.01%
2018-12-31 CN¥4.17 Billion
≈ $610.18 Million
CN¥510.71 Million
≈ $74.73 Million
0.122x +22.77%
2017-12-31 CN¥3.18 Billion
≈ $465.28 Million
CN¥317.20 Million
≈ $46.42 Million
0.100x +112.11%
2016-12-31 CN¥2.98 Billion
≈ $435.39 Million
CN¥139.94 Million
≈ $20.48 Million
0.047x -63.22%
2015-12-31 CN¥1.42 Billion
≈ $207.70 Million
CN¥181.52 Million
≈ $26.56 Million
0.128x -64.12%
2014-12-31 CN¥595.76 Million
≈ $87.18 Million
CN¥212.35 Million
≈ $31.07 Million
0.356x +14.22%
2013-12-31 CN¥502.20 Million
≈ $73.49 Million
CN¥156.71 Million
≈ $22.93 Million
0.312x +64.60%
2012-12-31 CN¥425.82 Million
≈ $62.31 Million
CN¥80.73 Million
≈ $11.81 Million
0.190x -45.08%
2011-12-31 CN¥356.28 Million
≈ $52.14 Million
CN¥122.99 Million
≈ $18.00 Million
0.345x --

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers
Market Cap
$4.80 Billion
CN¥32.82 Billion CNY
Market Cap Rank
#3558 Global
#456 in China
Share Price
CN¥27.07
Change (1 day)
+1.46%
52-Week Range
CN¥17.98 - CN¥27.34
All Time High
CN¥967.78
About

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to… Read more